Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNγ signaling in non-small cell lung cancer.
<h4>Background</h4>In non-small cell lung cancer (NSCLC), PD-L1 expression on either tumor cells (TC) or both TC and tumor-infiltrating immune cells (IC) is currently the most used biomarker in cancer immunotherapy. However, the mechanisms involved in PD-L1 regulation are not fully under...
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0216864 |
id |
doaj-71ec07804c5045b0afac420650e42855 |
---|---|
record_format |
Article |
spelling |
doaj-71ec07804c5045b0afac420650e428552021-03-04T10:30:45ZengPublic Library of Science (PLoS)PLoS ONE1932-62032019-01-01145e021686410.1371/journal.pone.0216864Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNγ signaling in non-small cell lung cancer.Willemijn S M E TheelenThomas KuilmanKatja SchulzeWei ZouOscar KrijgsmanDennis D G C PetersSten CornelissenKim MonkhorstPranamee SarmaTeiko SumiyoshiLukas C AmlerStefan M WillemsJohannes L G BlaauwgeersCarel J M van NoeselDaniel S PeeperMichel M van den HeuvelMarcin Kowanetz<h4>Background</h4>In non-small cell lung cancer (NSCLC), PD-L1 expression on either tumor cells (TC) or both TC and tumor-infiltrating immune cells (IC) is currently the most used biomarker in cancer immunotherapy. However, the mechanisms involved in PD-L1 regulation are not fully understood. To provide better insight in these mechanisms, a multiangular analysis approach was used to combine protein and mRNA expression with several clinicopathological characteristics.<h4>Patients and methods</h4>Archival tissues from 640 early stage, resected NSCLC patients were analyzed with immunohistochemistry for expression of PD-L1 and CD8 infiltration. In addition, mutational status and expression of a selection of immune genes involved in the PD-L1/PD-1 axis and T-cell response was determined.<h4>Results</h4>Tumors with high PD-L1 expression on TC or on IC represent two subsets of NSCLC with minimal overlap. We observed that PD-L1 expression on IC irrespective of expression on TC is a good marker for inflammation within tumors. In the tumors with the highest IC expression and absent TC expression an association with reduced IFNγ downstream signaling in tumor cells was observed.<h4>Conclusions</h4>These results show that PD-L1 expression on TC and IC are both independent hallmarks of the inflamed phenotype in NSCLC, and TC-negative/IC-high tumors can also be categorized as inflamed. The lack of correlation between PD-L1 TC and IC expression in this subgroup may be caused by impaired IFNγ signaling in tumor cells. These findings may bring a better understanding of the tumor-immune system interaction and the clinical relevance of PD-L1 expression on IC irrespective of PD-L1 expression on TC.https://doi.org/10.1371/journal.pone.0216864 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Willemijn S M E Theelen Thomas Kuilman Katja Schulze Wei Zou Oscar Krijgsman Dennis D G C Peters Sten Cornelissen Kim Monkhorst Pranamee Sarma Teiko Sumiyoshi Lukas C Amler Stefan M Willems Johannes L G Blaauwgeers Carel J M van Noesel Daniel S Peeper Michel M van den Heuvel Marcin Kowanetz |
spellingShingle |
Willemijn S M E Theelen Thomas Kuilman Katja Schulze Wei Zou Oscar Krijgsman Dennis D G C Peters Sten Cornelissen Kim Monkhorst Pranamee Sarma Teiko Sumiyoshi Lukas C Amler Stefan M Willems Johannes L G Blaauwgeers Carel J M van Noesel Daniel S Peeper Michel M van den Heuvel Marcin Kowanetz Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNγ signaling in non-small cell lung cancer. PLoS ONE |
author_facet |
Willemijn S M E Theelen Thomas Kuilman Katja Schulze Wei Zou Oscar Krijgsman Dennis D G C Peters Sten Cornelissen Kim Monkhorst Pranamee Sarma Teiko Sumiyoshi Lukas C Amler Stefan M Willems Johannes L G Blaauwgeers Carel J M van Noesel Daniel S Peeper Michel M van den Heuvel Marcin Kowanetz |
author_sort |
Willemijn S M E Theelen |
title |
Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNγ signaling in non-small cell lung cancer. |
title_short |
Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNγ signaling in non-small cell lung cancer. |
title_full |
Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNγ signaling in non-small cell lung cancer. |
title_fullStr |
Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNγ signaling in non-small cell lung cancer. |
title_full_unstemmed |
Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNγ signaling in non-small cell lung cancer. |
title_sort |
absence of pd-l1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired ifnγ signaling in non-small cell lung cancer. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2019-01-01 |
description |
<h4>Background</h4>In non-small cell lung cancer (NSCLC), PD-L1 expression on either tumor cells (TC) or both TC and tumor-infiltrating immune cells (IC) is currently the most used biomarker in cancer immunotherapy. However, the mechanisms involved in PD-L1 regulation are not fully understood. To provide better insight in these mechanisms, a multiangular analysis approach was used to combine protein and mRNA expression with several clinicopathological characteristics.<h4>Patients and methods</h4>Archival tissues from 640 early stage, resected NSCLC patients were analyzed with immunohistochemistry for expression of PD-L1 and CD8 infiltration. In addition, mutational status and expression of a selection of immune genes involved in the PD-L1/PD-1 axis and T-cell response was determined.<h4>Results</h4>Tumors with high PD-L1 expression on TC or on IC represent two subsets of NSCLC with minimal overlap. We observed that PD-L1 expression on IC irrespective of expression on TC is a good marker for inflammation within tumors. In the tumors with the highest IC expression and absent TC expression an association with reduced IFNγ downstream signaling in tumor cells was observed.<h4>Conclusions</h4>These results show that PD-L1 expression on TC and IC are both independent hallmarks of the inflamed phenotype in NSCLC, and TC-negative/IC-high tumors can also be categorized as inflamed. The lack of correlation between PD-L1 TC and IC expression in this subgroup may be caused by impaired IFNγ signaling in tumor cells. These findings may bring a better understanding of the tumor-immune system interaction and the clinical relevance of PD-L1 expression on IC irrespective of PD-L1 expression on TC. |
url |
https://doi.org/10.1371/journal.pone.0216864 |
work_keys_str_mv |
AT willemijnsmetheelen absenceofpdl1expressionontumorcellsinthecontextofanactivatedimmuneinfiltratemayindicateimpairedifngsignalinginnonsmallcelllungcancer AT thomaskuilman absenceofpdl1expressionontumorcellsinthecontextofanactivatedimmuneinfiltratemayindicateimpairedifngsignalinginnonsmallcelllungcancer AT katjaschulze absenceofpdl1expressionontumorcellsinthecontextofanactivatedimmuneinfiltratemayindicateimpairedifngsignalinginnonsmallcelllungcancer AT weizou absenceofpdl1expressionontumorcellsinthecontextofanactivatedimmuneinfiltratemayindicateimpairedifngsignalinginnonsmallcelllungcancer AT oscarkrijgsman absenceofpdl1expressionontumorcellsinthecontextofanactivatedimmuneinfiltratemayindicateimpairedifngsignalinginnonsmallcelllungcancer AT dennisdgcpeters absenceofpdl1expressionontumorcellsinthecontextofanactivatedimmuneinfiltratemayindicateimpairedifngsignalinginnonsmallcelllungcancer AT stencornelissen absenceofpdl1expressionontumorcellsinthecontextofanactivatedimmuneinfiltratemayindicateimpairedifngsignalinginnonsmallcelllungcancer AT kimmonkhorst absenceofpdl1expressionontumorcellsinthecontextofanactivatedimmuneinfiltratemayindicateimpairedifngsignalinginnonsmallcelllungcancer AT pranameesarma absenceofpdl1expressionontumorcellsinthecontextofanactivatedimmuneinfiltratemayindicateimpairedifngsignalinginnonsmallcelllungcancer AT teikosumiyoshi absenceofpdl1expressionontumorcellsinthecontextofanactivatedimmuneinfiltratemayindicateimpairedifngsignalinginnonsmallcelllungcancer AT lukascamler absenceofpdl1expressionontumorcellsinthecontextofanactivatedimmuneinfiltratemayindicateimpairedifngsignalinginnonsmallcelllungcancer AT stefanmwillems absenceofpdl1expressionontumorcellsinthecontextofanactivatedimmuneinfiltratemayindicateimpairedifngsignalinginnonsmallcelllungcancer AT johanneslgblaauwgeers absenceofpdl1expressionontumorcellsinthecontextofanactivatedimmuneinfiltratemayindicateimpairedifngsignalinginnonsmallcelllungcancer AT careljmvannoesel absenceofpdl1expressionontumorcellsinthecontextofanactivatedimmuneinfiltratemayindicateimpairedifngsignalinginnonsmallcelllungcancer AT danielspeeper absenceofpdl1expressionontumorcellsinthecontextofanactivatedimmuneinfiltratemayindicateimpairedifngsignalinginnonsmallcelllungcancer AT michelmvandenheuvel absenceofpdl1expressionontumorcellsinthecontextofanactivatedimmuneinfiltratemayindicateimpairedifngsignalinginnonsmallcelllungcancer AT marcinkowanetz absenceofpdl1expressionontumorcellsinthecontextofanactivatedimmuneinfiltratemayindicateimpairedifngsignalinginnonsmallcelllungcancer |
_version_ |
1714805713442701312 |